1. L. Shargel and A. B. C. Yu.Applied Biopharmaceutics and Pharmacokinetics, 2nd ed., Appleton-Century-Crofts, Norwalk, CT, 1985, pp. 197–211.
2. J. B. Whitlan and K. F. Brown. Ultrafiltration in serum protein binding determinations.J. Pharm. Sci. 70:146–150 (1981).
3. J. Kurz, J. Trunk, and B. Weitz. Evaluation of methods to determine protein-binding of drugs, equilibrium dialysis, ultrafiltration, ultracentrifugation, and gel filtration.Drug Res. 27:1373–1380 (1977).
4. G. W. Moll and R. L. Rosenfeld. Some limitations of using equilibrium dialysis to study human serum albumin-testosterone interaction.J. Clin. Endocrinal. Metab. 46:501–503 (1978).
5. P. A. Bombardt, J. E. Brewer, and M. G. Johnson. Protein binding of Tirilazad (U-74006) in human, Sprague-Dawley rat, Beagle dog and cynomolgus monkey serum.J. Pharmacol. Exp. Ther. 269:145–150 (1994).